Area of research
Pharmacology · Cognitive Neuroscience
Research interest
Research focused on Antidepressant and Depression (economics), with related work in Major depressive disorder, Modafinil, Clinical trial. Notable publications include 'Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects', 'Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis', and 'Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial'.
Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder
Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis
A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial
An overview on clinical aspects in magnetic seizure therapy
Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects